Vascular Grafts Market Emergence Of Advanced
Technologies And Global Industry Analysis 2026!! Key
Players Medtronic Plc., Vascutek Ltd, W.L. Gore &
Associates, Inc.
Vascular Grafts are medical devices used to bypass the infected or diseased blood vessels.
Vascular grafts are required to replace injured blood vessels, veins, and arteries and to
substitute hard blood vessels or valves. Blood flow is redirected from one place to another by
introducing a graft with the help of surgical reconstruction process. These grafts can be
synthetic, semi-synthetic or taken from the patient’s body.
Request Sample Copy of Research Report @
https://www.coherentmarketinsights.com/insight/request-sample/1075
Vascular grafts are majorly used in treatment of cardiovascular diseases by surgical procedures
such as bypass grafting. The graft is taken from the patient’s body and surgically inserted at
the required site to bypass the damaged or diseased blood vessels. Factors such as smoking,
high blood pressure, atherosclerosis, and diabetes lead to chronic heart diseases in turn
increasing the demand for effective and life sustaining treatment. Bypass surgeries are
performed in patients suffering from coronary artery diseases, angina pectoris, heart attack,
atherosclerosis, diabetes, and multiple heart artery blockages.
Rising prevalence of coronary artery diseases is expected to boost the growth of vascular grafts
market
According to Centers for Disease Control and Prevention (CDC) in 2016, approximately 8.5
million people in the U.S. had peripheral arterial diseases with healthcare costs accounting for
US$ 21 billion annually. Increasing requirement for treatment with bypass surgeries is expected
to boost the growth of vascular grafts market.
Age is also a risk factor for coronary artery diseases. In 2015, around 44 million people over
age 60 were suffering from coronary artery diseases in the U.S. according to American Heart
Association (AHA). Furthermore, according to the AHA in 2017, around 92 million American
adults are suffering from cardiovascular diseases, which is expected to fuel the growth of
vascular grafts market.